WallStSmart
BYSI

BeyondSpring Inc

NASDAQ: BYSI · HEALTHCARE · BIOTECHNOLOGY

$1.55
+1.96% today

Updated 2026-05-01

Market cap
$60.45M
P/E ratio
P/S ratio
45.99x
EPS (TTM)
$-0.21
Dividend yield
52W range
$1 – $3
Volume
0.0M

WallStSmart proprietary scores

20
out of 100
Grade: F
Strong Sell
Investment rating
5.0
Growth
C+
5.0
Quality
C+
3.0
Profitability
D
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$1.25
-19.35%
12-Month target
Intrinsic (DCF)
$11.09
Margin of safety
+87.20%

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 14.30% QoQ
+ 87.20% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-5.65M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$1.35M$1.75M$0.00$0.00$1.88M
Net income$-33.28M$-21.03M$-11.12M$-7.99M$-9.12M
EPS$-0.21
Free cash flow$-28.18M$-16.57M$-16.67M$-20.07M$-5.65M
Profit margin-2,463.29%-1,200.80%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
BYSI$60.45M205.03.06.75.0+87.20%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-26.29%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

BeyondSpring Inc trades at $1.55. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $1.88M. Our DCF model estimates intrinsic value at $11.09.

Frequently asked questions

What is BeyondSpring Inc's stock price?
BeyondSpring Inc (BYSI) trades at $1.55.
Is BeyondSpring Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $11.09.
What is the price target of BeyondSpring Inc (BYSI)?
The analyst target price is $1.25, representing -19.4% downside from the current price of $1.55.
What is the intrinsic value of BeyondSpring Inc (BYSI)?
Based on our DCF model, intrinsic value is $11.09, a +87.2% margin of safety versus $1.55.
What is BeyondSpring Inc's revenue?
TTM revenue is $1.88M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio45.99x
ROE-310.50%
Beta0.51
50D MA$1.59
200D MA$1.78
Shares out0.04B
Float0.03B
Short ratio
Avg volume0.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years